Showing results (651-660 of 794) with videos related to
Sort By:
Pageof 80
Urology|April 15, 2014
Weight gain on androgen deprivation therapy: which patients are at highest risk?Daniel M Seible, Xiangmei Gu, Andrew S Hyatt, et al.The Prostate|August 22, 2006
Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer modelRajasubramaniam Shanmugam, Vetrichelvan Jayaprakasan, Yesim Gokmen-Polar, et al.European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinomaMatthew I Milowsky, Christian Dittrich, Ignacio Durán, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
PC cell-derived growth factor expression in prostatic intraepithelial neoplasia and prostatic adenocarcinomaChong-Xian Pan, Michael S Kinch, Peter A Kiener, et al.Journal of the National Comprehensive Cancer Network : JNCCN|April 10, 2016
Variation in National Use of Long-Term ADT by Disease Aggressiveness Among Men With Unfavorable-Risk Prostate CancerVinayak Muralidhar, Paul J Catalano, Gally Reznor, et al.Nature Protocols|June 28, 2020
FiTAc-seq: fixed-tissue ChIP-seq for H3K27ac profiling and super-enhancer analysis of FFPE tissuesAlba Font-Tello, Nikolas Kesten, Yingtian Xie, et al.European Urology Oncology|April 17, 2025
Genetic Drivers of Quality of Life in Prostate Cancer: An Evaluation of Genetic Polymorphisms and Patient-reported Outcomes in the E3805 CHAARTED trialDaniel Sentana-Lledo, Xiangying Chu, Charles J Ryan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2016
A Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy With or Without Bevacizumab for Patients With Recurrent Prostate Cancer After Definitive Local TherapyRana R McKay, Amado J Zurita, Lillian Werner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2020
Dual Blockade of c-MET and the Androgen Receptor in Metastatic Castration-resistant Prostate Cancer: A Phase I Study of Concurrent Enzalutamide and CrizotinibAbhishek Tripathi, Jeffrey G Supko, Kathryn P Gray, et al.Cancers|December 1, 2020
Targeting the RhoGEF βPIX/COOL-1 in Glioblastoma: Proof of Concept StudiesKate Connor, David W Murray, Monika A Jarzabek, et al.Pageof 80